Search

everythinglearnresearchcommunity

for

Search:↓

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

COVID-19 infection or vaccination may influence the development of alopecia areata, a type of hair loss.

γδ T cells are crucial for early wound healing after a skin virus infection.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

A rabbit with sebaceous adenitis was effectively treated with ciclosporin and medium-chain triglycerides.

Adalimumab helped control a child's severe eye disease when other treatments failed.

A Chinese boy's scalp infection from a guinea pig was cured with medication.

More research is needed to understand and treat cicatricial alopecias.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

JAM-A modification speeds up skin wound healing by boosting fibroblast growth.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Most tinea capitis patients were young boys with cat contact, had scaly patches caused by Microsporum canis, and improved with griseofulvin treatment.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Flightless I protein affects hair growth, with low levels delaying it and high levels increasing hair length in rodents.

Flavin prevents cataracts in young rats.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Suppressing eIF4E can prevent hair loss from chemotherapy.

This method is effective for needle-free HIV-1 vaccination by activating immune responses in the skin.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

SLE should be considered in horses with immune-related skin issues.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.